PowerVision Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 500
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $424M
Latest Deal Amount

PowerVision General Information

Description

Developer of implantable intraocular lenses designed to restore the vision of individuals affected by presbyopia or cataracts. The company's lenses offers fluid-based lens implants that meet the clinical and lifestyle needs caused by presbyopia and cataracts and are used to develop the most significant innovation in vision correction surgery, enabling young, middle-aged and elderly patients to regain their clear vision.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • 298 Harbor Boulevard
  • Belmont, CA 94002
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PowerVision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 13-Mar-2019 $424M 00000 00000 Completed Generating Revenue
7. Later Stage VC (Series D) 09-Aug-2018 0000 00000 00000 Completed Generating Revenue
6. Debt - General 22-Nov-2017 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 26-Jul-2016 000.00 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 23-Jan-2012 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 12-Feb-2008 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 17-Mar-2006 $2M $11.7M Completed Startup
1. Early Stage VC (Series A) 01-Dec-2004 $9.7M $9.7M 000.00 Completed Startup
To view PowerVision’s complete valuation and funding history, request access »

PowerVision Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 26,871,774 $0.001000 8% $0.76 $0.76 1x $0.64 10.76%
Series A 20,610,978 $0.001000 8% $0.46 $0.46 1x $0.46 7.09%
To view PowerVision’s complete cap table history, request access »

PowerVision Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of implantable intraocular lenses designed to restore the vision of individuals affected by presbyopia or cata
Therapeutic Devices
Belmont, CA
500 As of 2020
00000
0000 0000-00-00
000000&0 00000

0000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
00000000 0000000
Liège, Belgium
00 As of 0000
00000
0000 0000-00-00
000000000000 00000

00000000

dunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
00000000000 0000000
Irvine, CA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PowerVision Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PhysIOL Private Equity-Backed Liège, Belgium 00 00000 000000000000 00000
00000000 Private Equity-Backed Irvine, CA 00 00000 00000000000 00000
0000000 Corporation Farmingdale, NY 000 000000000 -
To view PowerVision’s complete competitors history, request access »

PowerVision Executive Team (13)

Name Title Board Seat Contact Info
Barry Cheskin Co-Founder, Board Member, President & Chief Executive Officer
David Chazan Program Director, Materials
David Sanderson Vice President, Manufacturing, Quality and Program Management
Matthew Frinzi Co-Founder & Board Member
Bettina Kohler Senior Director, Clinical Marketing and Professional Education
You’re viewing 5 of 13 executive team members. Get the full list »

PowerVision Board Members (10)

Name Representing Role Since
James McCollum Self Board Member 000 0000
Louis Bock Self Board Member 000 0000
Matthew Frinzi PowerVision Co-Founder & Board Member 000 0000
You’re viewing 3 of 10 board members. Get the full list »

PowerVision Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PowerVision Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advanced Technology Ventures Venture Capital Minority 000 0000 000000 0
Aisling Capital Venture Capital Minority 000 0000 000000 0
Archer Venture Capital Venture Capital Minority 000 0000 000000 0
Correlation Ventures Venture Capital Minority 000 0000 000000 0
Frazier Healthcare Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »